Eco Animal Health Group PLC Announces Major Shareholder Disclosure
The healthcare company has received a notification from a major shareholder, Schroders PLC, regarding changes to its shareholding position.
The healthcare company has received a notification from a major shareholder, Schroders PLC, regarding changes to its shareholding position.
The healthcare company's CEO has purchased additional shares in the business.
The animal health company reports EBITDA ahead of market forecasts, driven by strong gross margins and cost control.
The healthcare company is hosting an R&D Day to showcase its pipeline of new veterinary products and how they will drive future growth.
The healthcare company has submitted its first EU vaccine application for regulatory approval, marking an important milestone in its R&D pipeline.
The retailer has announced a routine regulatory notification of a change in shareholding, with no material impact on the business.
The healthcare company has sold non-core product lines to its South African distribution partner for £491,000, allowing it to focus on its core pigs and poultry business and reinvest in R&D.
The animal health company is hosting an R&D Day for investors to showcase its pipeline and long-term value creation.
The animal health company announces the retirement of its long-serving Chairman and the appointment of a new Chairman with extensive industry experience, as part of a planned succession process.
Routine shareholding change announcement for this small-cap pharmaceutical company, with no significant impact on the business.